Eirik Sundby

846 citations

62 papers · 699 indexed · h-index 17

Co-authors: Bård Helge Hoff T. Anthonsen Geir Bjørkøy Kristin G. Nørsett Colin Charnock Mohammed Farrag El‐Behairy Jin Han Unni Nonstad
Topics: Enzyme Catalysis and Immobilization (12 papers)Quinazolinone synthesis and applications (12 papers)Cancer therapeutics and mechanisms (9 papers)
Cited by: Organic Chemistry Pharmaceutical Science Process Chemistry and Technology
Journals: Analytical Biochemistry Journal of Medicinal Chemistry Tetrahedron
Partner nations: Norway Egypt Slovakia

In The Last Decade

Eirik Sundby

57 papers receiving 690 citations

Peers

Countries citing papers authored by Eirik Sundby

Since Specialization

Citations

This map shows the geographic impact of Eirik Sundby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eirik Sundby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eirik Sundby more than expected).

Fields of papers citing papers by Eirik Sundby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eirik Sundby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eirik Sundby. The network helps show where Eirik Sundby may publish in the future.

Co-authorship network of co-authors of Eirik Sundby

This figure shows the co-authorship network connecting the top 25 collaborators of Eirik Sundby. A scholar is included among the top collaborators of Eirik Sundby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eirik Sundby. Eirik Sundby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis and evaluation of fluorinated tetrahydrocarbazoles as probes in NMR based binding assay of the E. coli β sliding clamp 2025 ·Bioorganic & Medicinal Chemistry ·(unknown),(unknown),(unknown),Václav Eigner,Finn L. Aachmann,Birthe B. Kragelund,Eirik Sundby,Bård Helge Hoff	0
2	Improved Synthetic Methodology, Substrate Scope and X‐ray Crystal Structure for N , N’ ‐disubstituted Guanidines 2024 ·ChemistrySelect ·(unknown),Václav Eigner,Torkild Visnes,Eirik Sundby,Bård Helge Hoff	0
3	Activation of multiple stress responses in Staphylococcus aureus substantially lowers the minimal inhibitory concentration when combining two novel antibiotic drug candidates 2023 ·Frontiers in Microbiology ·(unknown),(unknown),(unknown),Lisa Marie Røst,(unknown),(unknown),(unknown),(unknown),Eirik Sundby,Bård Helge Hoff,Per Bruheim,Marit Otterlei	2
4	Directed Lithiation of Protected 4-Chloropyrrolopyrimidine: Addition to Aldehydes and Ketones Aided by Bis(2-dimethylaminoethyl)ether 2023 ·Molecules ·(unknown),Eirik Sundby,Bård Helge Hoff	2
5	A highly selective purine-based inhibitor of CSF1R potently inhibits osteoclast differentiation 2023 ·European Journal of Medicinal Chemistry ·(unknown),Jan Eickhoff,Bert Klebl,Anke Unger,Joanna Boros,Axel Choidas,(unknown),(unknown),Geir Bjørkøy,Eirik Sundby,Bård Helge Hoff	7
6	Potent and selective EGFR inhibitors based on 5-aryl-7H-pyrrolopyrimidin-4-amines 2019 ·Bioorganic Chemistry ·(unknown),(unknown),(unknown),Kristin G. Nørsett,Eirik Sundby,Bård Helge Hoff	12
7	Identification of fused pyrimidines as interleukin 17 secretion inhibitors 2018 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),Eirik Sundby,Bård Helge Hoff	9
8	Changes in cellular signaling proteins in extracts from A549, H460, and U2OS cells treated with cisplatin or docetaxel 2017 ·Data in Brief ·(unknown),(unknown),Animesh Sharma,(unknown),(unknown),Eirik Sundby,Bård Helge Hoff,Geir Slupphaug,Marit Otterlei	1
9	On-column trypsinization allows for re-use of matrix in modified multiplexed inhibitor beads assay 2017 ·Analytical Biochemistry ·(unknown),(unknown),Animesh Sharma,(unknown),(unknown),Eirik Sundby,Bård Helge Hoff,Geir Slupphaug,Marit Otterlei	9
10	Is literature data useful for identifying enzyme catalysts for new substrates? A case study on reduction of 1-aryl-2-alkanoates 2017 ·Bioorganic Chemistry ·Bård Helge Hoff,Eirik Sundby	2
11	Extended structure–activity study of thienopyrimidine-based EGFR inhibitors with evaluation of drug-like properties 2015 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),Nathalie Jurisch‐Yaksi,(unknown),(unknown),Eirik Sundby,Bård Helge Hoff	42
12	In vitro baselining of new pyrrolopyrimidine EGFR-TK inhibitors with Erlotinib 2015 ·European Journal of Pharmaceutical Sciences ·Eirik Sundby,Jin Han,(unknown),Bård Helge Hoff	10
13	Structure–activity study leading to identification of a highly active thienopyrimidine based EGFR inhibitor 2014 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),Unni Nonstad,Geir Bjørkøy,Eirik Sundby,Bård Helge Hoff	57
14	Preparation of pharmaceutical important fluorinated 1-arylethanols using isolated enzymes 2013 ·Bioorganic Chemistry ·Bård Helge Hoff,Eirik Sundby	16
15	Chiral N-benzyl-N-methyl-1-(naphthalen-1-yl)ethanamines and their in vitro antifungal activity against Cryptococcus neoformans, Trichophyton mentagrophytes and Trichophyton rubrum 2013 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),Eirik Sundby,Colin Charnock,Bård Helge Hoff	10
16	Synthesis and in vitro EGFR (ErbB1) tyrosine kinase inhibitory activity of 4-N-substituted 6-aryl-7H-pyrrolo[2,3-d]pyrimidine-4-amines 2011 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),(unknown),(unknown),Geir Bjørkøy,Eirik Sundby,Bård Helge Hoff	30
17	Expression of UDP-glucuronosyltransferase 1A4 in human placenta at term 2010 ·European Journal of Drug Metabolism and Pharmacokinetics ·Arne Reimers,(unknown),(unknown),Eirik Sundby	15
18	¹H and ¹³C NMR data of methyl tetra‐O‐benzoyl‐D‐pyranosides in acetone‐d₆ 2009 ·Magnetic Resonance in Chemistry ·(unknown),Nebojša Simić,Eirik Sundby,Bård Helge Hoff	9
19	¹H,¹³C and ¹⁹F NMR data of N‐substituted 6‐(4‐methoxyphenyl)‐7H‐pyrrolo[2,3‐d]pyrimidin‐4‐amines in DMSO‐d₆ 2009 ·Magnetic Resonance in Chemistry ·(unknown),Nebojša Simić,Eirik Sundby,Bård Helge Hoff	2
20	Nitration of Pyridine Compounds. The Reaction of N-Nitro-1,4-dihydro-4-pyridinesulfonic Acid. 1999 ·Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry ·Jan M. Bakke,(unknown),(unknown),Lars Skattebøl,Eirik Sundby,Carsten Christophersen,Honggen Wang,Xin‐Kan Yao,Jean‐Pierre Tuchagues,Mattias Ögren	5

About Eirik Sundby

Eirik Sundby is a scholar working on Organic Chemistry, Pharmaceutical Science and Process Chemistry and Technology, having authored 62 papers that have together received 699 indexed citations. Recurring topics across this work include Enzyme Catalysis and Immobilization (12 papers), Quinazolinone synthesis and applications (12 papers) and Cancer therapeutics and mechanisms (9 papers). The work is most often cited by research in Organic Chemistry (421 citations), Pharmaceutical Science (84 citations) and Process Chemistry and Technology (26 citations). Eirik Sundby has collaborated with scholars based in Norway, Egypt and Slovakia. Frequent co-authors include Bård Helge Hoff, T. Anthonsen, Geir Bjørkøy, Kristin G. Nørsett, Colin Charnock, Mohammed Farrag El‐Behairy, Jin Han, Unni Nonstad, Trond Vidar Hansen and Arne Jørgen Aasen. Their work appears in journals such as Analytical Biochemistry, Journal of Medicinal Chemistry and Tetrahedron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact